VYGR – Voyager Therapeutics Inc.
VYGR — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
6.5
Margin Of Safety %
Put/Call OI Ratio
0.08
EPS Next Q Diff
-0.02
EPS Last/This Y
0.27
EPS This/Next Y
0.06
Price
3.97
Target Price
14.89
Analyst Recom
1.08
Performance Q
-2.94
Upside
-769.7%
Beta
1.4
Ticker: VYGR
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | VYGR | 4.12 | 0.04 | 2.50 | 5831 |
| 2026-03-10 | VYGR | 4.99 | 0.05 | 0.14 | 5842 |
| 2026-03-11 | VYGR | 4.88 | 0.05 | 0.03 | 7024 |
| 2026-03-12 | VYGR | 4.86 | 0.05 | 0.06 | 7136 |
| 2026-03-13 | VYGR | 4.87 | 0.05 | 0.06 | 7136 |
| 2026-03-17 | VYGR | 3.93 | 0.06 | 0.06 | 7320 |
| 2026-03-18 | VYGR | 3.77 | 0.06 | 1.75 | 7119 |
| 2026-03-19 | VYGR | 3.73 | 0.06 | 1.40 | 7157 |
| 2026-03-20 | VYGR | 3.85 | 0.07 | 0.07 | 7153 |
| 2026-03-23 | VYGR | 3.88 | 0.04 | 8.83 | 6267 |
| 2026-03-24 | VYGR | 3.92 | 0.05 | 0.00 | 6297 |
| 2026-03-25 | VYGR | 4.03 | 0.05 | 0.16 | 6303 |
| 2026-03-26 | VYGR | 4.14 | 0.05 | 0.00 | 6369 |
| 2026-03-27 | VYGR | 3.97 | 0.05 | 7.76 | 6713 |
| 2026-03-30 | VYGR | 3.88 | 0.08 | 0.00 | 6939 |
| 2026-03-31 | VYGR | 3.87 | 0.08 | 0.00 | 6939 |
| 2026-04-01 | VYGR | 3.98 | 0.08 | 0.00 | 6941 |
| 2026-04-02 | VYGR | 3.95 | 0.08 | 0.00 | 6939 |
| 2026-04-06 | VYGR | 3.97 | 0.08 | 0.00 | 6936 |
| 2026-04-07 | VYGR | 3.96 | 0.08 | 0.00 | 7047 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | VYGR | 4.11 | 12.9 | - | -2.09 |
| 2026-03-10 | VYGR | 4.99 | 12.9 | - | -2.09 |
| 2026-03-11 | VYGR | 4.84 | 12.9 | - | -2.09 |
| 2026-03-12 | VYGR | 4.87 | 12.9 | - | -2.09 |
| 2026-03-13 | VYGR | 4.45 | -4.7 | - | -1.76 |
| 2026-03-17 | VYGR | 3.93 | -5.4 | - | -1.85 |
| 2026-03-18 | VYGR | 3.77 | -5.4 | - | -1.85 |
| 2026-03-19 | VYGR | 3.73 | -5.4 | - | -1.85 |
| 2026-03-20 | VYGR | 3.85 | 2.7 | - | -1.77 |
| 2026-03-23 | VYGR | 3.88 | 2.7 | - | -1.77 |
| 2026-03-24 | VYGR | 3.92 | 2.7 | - | -1.77 |
| 2026-03-25 | VYGR | 4.04 | 2.7 | - | -1.77 |
| 2026-03-26 | VYGR | 4.14 | 2.7 | - | -1.77 |
| 2026-03-27 | VYGR | 3.97 | 2.7 | - | -1.77 |
| 2026-03-30 | VYGR | 3.86 | 2.7 | - | -1.77 |
| 2026-03-31 | VYGR | 3.86 | 2.7 | - | -1.77 |
| 2026-04-01 | VYGR | 3.98 | 2.7 | - | -1.77 |
| 2026-04-02 | VYGR | 3.95 | 2.7 | - | -1.77 |
| 2026-04-06 | VYGR | 3.97 | 2.7 | - | -1.77 |
| 2026-04-07 | VYGR | 3.97 | 2.7 | - | -1.77 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | VYGR | -0.76 | 1.70 | 7.35 |
| 2026-03-10 | VYGR | -0.76 | 1.70 | 7.35 |
| 2026-03-11 | VYGR | -0.76 | 1.70 | 7.00 |
| 2026-03-12 | VYGR | -0.71 | 1.70 | 6.53 |
| 2026-03-13 | VYGR | -0.71 | 1.70 | 6.53 |
| 2026-03-17 | VYGR | -0.71 | 1.42 | 6.53 |
| 2026-03-18 | VYGR | -0.71 | 1.42 | 6.53 |
| 2026-03-19 | VYGR | -0.71 | 1.42 | 6.53 |
| 2026-03-20 | VYGR | -0.71 | 1.42 | 6.53 |
| 2026-03-23 | VYGR | -0.71 | 1.42 | 6.53 |
| 2026-03-24 | VYGR | -0.71 | 1.42 | 6.53 |
| 2026-03-25 | VYGR | -0.71 | 1.42 | 6.50 |
| 2026-03-26 | VYGR | -0.71 | 1.42 | 6.50 |
| 2026-03-27 | VYGR | -0.71 | 1.42 | 6.50 |
| 2026-03-30 | VYGR | -0.71 | 1.42 | 6.50 |
| 2026-03-31 | VYGR | -0.71 | 1.42 | 6.50 |
| 2026-04-01 | VYGR | -0.71 | 1.42 | 6.50 |
| 2026-04-02 | VYGR | -0.71 | 1.42 | 6.50 |
| 2026-04-06 | VYGR | -0.81 | 1.42 | 6.50 |
| 2026-04-07 | VYGR | -0.81 | 1.42 | 6.50 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.46
Avg. EPS Est. Current Quarter
-0.52
Avg. EPS Est. Next Quarter
-0.48
Insider Transactions
-0.81
Institutional Transactions
1.42
Beta
1.4
Average Sales Estimate Current Quarter
8
Average Sales Estimate Next Quarter
9
Fair Value
Quality Score
18
Growth Score
30
Sentiment Score
40
Actual DrawDown %
72.3
Max Drawdown 5-Year %
-80.5
Target Price
14.89
P/E
Forward P/E
PEG
P/S
5.85
P/B
1.19
P/Free Cash Flow
EPS
-2.04
Average EPS Est. Cur. Y
-1.77
EPS Next Y. (Est.)
-1.71
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-296.53
Relative Volume
0.79
Return on Equity vs Sector %
-88.5
Return on Equity vs Industry %
-72
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.21
EBIT Estimation
◆
VYGR
Healthcare
$3.96
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
48.7
Range 1M
15.9%
Sup Dist
2.3%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
11.2%
EPS NY
5%
52W%
44.6%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+276% upside
Upside
+276%
Quality
18
Voyager Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 141
Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease. The company also provides research program for the treatment of Huntington's disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia with TDP-43 pathology. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Transition Bio, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
VYGR
Latest News
—
Caricamento notizie per VYGR…
stock quote shares VYGR – Voyager Therapeutics Inc. Stock Price stock today
news today VYGR – Voyager Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VYGR – Voyager Therapeutics Inc. yahoo finance google finance
stock history VYGR – Voyager Therapeutics Inc. invest stock market
stock prices VYGR premarket after hours
ticker VYGR fair value insiders trading